vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and IDT CORP (IDT). Click either name above to swap in a different company.

IDT CORP is the larger business by last-quarter revenue ($322.8M vs $196.0M, roughly 1.6× Axsome Therapeutics, Inc.). IDT CORP runs the higher net margin — 6.9% vs -14.6%, a 21.5% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 4.3%). IDT CORP produced more free cash flow last quarter ($-16.0M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 4.4%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

IDT Corporation is a multinational provider of cloud communications, point of sale systems, unified communications, and financial services foreign exchange services for selected clients. It has units dedicated for businesses and consumers such as the Boss Revolution pre-paid phone cards, headquartered in Newark, New Jersey.

AXSM vs IDT — Head-to-Head

Bigger by revenue
IDT
IDT
1.6× larger
IDT
$322.8M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+60.8% gap
AXSM
65.0%
4.3%
IDT
Higher net margin
IDT
IDT
21.5% more per $
IDT
6.9%
-14.6%
AXSM
More free cash flow
IDT
IDT
$2.8M more FCF
IDT
$-16.0M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
4.4%
IDT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXSM
AXSM
IDT
IDT
Revenue
$196.0M
$322.8M
Net Profit
$-28.6M
$22.4M
Gross Margin
36.6%
Operating Margin
-13.8%
9.6%
Net Margin
-14.6%
6.9%
Revenue YoY
65.0%
4.3%
Net Profit YoY
61.9%
29.6%
EPS (diluted)
$-0.55
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
IDT
IDT
Q4 25
$196.0M
$322.8M
Q3 25
$171.0M
$316.6M
Q2 25
$150.0M
$302.0M
Q1 25
$121.5M
$303.3M
Q4 24
$118.8M
$309.6M
Q3 24
$104.8M
$308.8M
Q2 24
$87.2M
$299.6M
Q1 24
$75.0M
$296.1M
Net Profit
AXSM
AXSM
IDT
IDT
Q4 25
$-28.6M
$22.4M
Q3 25
$-47.2M
$16.9M
Q2 25
$-48.0M
$21.7M
Q1 25
$-59.4M
$20.3M
Q4 24
$-74.9M
$17.2M
Q3 24
$-64.6M
$36.8M
Q2 24
$-79.3M
$5.6M
Q1 24
$-68.4M
$14.4M
Gross Margin
AXSM
AXSM
IDT
IDT
Q4 25
36.6%
Q3 25
36.2%
Q2 25
37.1%
Q1 25
37.0%
Q4 24
34.8%
Q3 24
33.1%
Q2 24
32.4%
Q1 24
32.7%
Operating Margin
AXSM
AXSM
IDT
IDT
Q4 25
-13.8%
9.6%
Q3 25
-27.0%
6.9%
Q2 25
-24.5%
8.8%
Q1 25
-46.9%
9.3%
Q4 24
-61.1%
7.6%
Q3 24
-59.8%
6.5%
Q2 24
-89.5%
3.8%
Q1 24
-89.7%
5.4%
Net Margin
AXSM
AXSM
IDT
IDT
Q4 25
-14.6%
6.9%
Q3 25
-27.6%
5.3%
Q2 25
-32.0%
7.2%
Q1 25
-48.9%
6.7%
Q4 24
-63.1%
5.6%
Q3 24
-61.7%
11.9%
Q2 24
-91.0%
1.9%
Q1 24
-91.1%
4.9%
EPS (diluted)
AXSM
AXSM
IDT
IDT
Q4 25
$-0.55
$0.89
Q3 25
$-0.94
$0.67
Q2 25
$-0.97
$0.86
Q1 25
$-1.22
$0.80
Q4 24
$-1.54
$0.68
Q3 24
$-1.34
$1.45
Q2 24
$-1.67
$0.22
Q1 24
$-1.44
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
IDT
IDT
Cash + ST InvestmentsLiquidity on hand
$322.9M
$189.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
$320.7M
Total Assets
$689.8M
$654.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
IDT
IDT
Q4 25
$322.9M
$189.3M
Q3 25
$325.3M
$226.5M
Q2 25
$303.0M
$199.9M
Q1 25
$300.9M
$142.2M
Q4 24
$315.4M
$148.0M
Q3 24
$327.3M
$164.6M
Q2 24
$315.7M
$139.8M
Q1 24
$331.4M
$141.1M
Stockholders' Equity
AXSM
AXSM
IDT
IDT
Q4 25
$88.3M
$320.7M
Q3 25
$73.7M
$305.1M
Q2 25
$73.1M
$286.2M
Q1 25
$53.2M
$271.6M
Q4 24
$57.0M
$260.6M
Q3 24
$92.9M
$246.2M
Q2 24
$102.9M
$214.5M
Q1 24
$144.0M
$211.8M
Total Assets
AXSM
AXSM
IDT
IDT
Q4 25
$689.8M
$654.9M
Q3 25
$669.3M
$626.2M
Q2 25
$639.8M
$600.9M
Q1 25
$596.7M
$575.7M
Q4 24
$568.5M
$554.6M
Q3 24
$561.5M
$550.1M
Q2 24
$548.2M
$517.3M
Q1 24
$545.7M
$521.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
IDT
IDT
Operating Cash FlowLast quarter
$-18.7M
$-10.1M
Free Cash FlowOCF − Capex
$-18.7M
$-16.0M
FCF MarginFCF / Revenue
-9.6%
-4.9%
Capex IntensityCapex / Revenue
0.0%
1.8%
Cash ConversionOCF / Net Profit
-0.45×
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$95.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
IDT
IDT
Q4 25
$-18.7M
$-10.1M
Q3 25
$1.0M
$31.0M
Q2 25
$-32.4M
$75.7M
Q1 25
$-43.4M
$20.2M
Q4 24
$-26.2M
$164.0K
Q3 24
$-18.6M
$25.4M
Q2 24
$-30.1M
$9.5M
Q1 24
$-53.5M
$28.4M
Free Cash Flow
AXSM
AXSM
IDT
IDT
Q4 25
$-18.7M
$-16.0M
Q3 25
$988.0K
$25.7M
Q2 25
$-32.4M
$70.3M
Q1 25
$-43.7M
$15.3M
Q4 24
$-26.2M
$-5.1M
Q3 24
$-18.7M
$20.1M
Q2 24
$-30.2M
$4.7M
Q1 24
$-53.6M
$23.9M
FCF Margin
AXSM
AXSM
IDT
IDT
Q4 25
-9.6%
-4.9%
Q3 25
0.6%
8.1%
Q2 25
-21.6%
23.3%
Q1 25
-36.0%
5.1%
Q4 24
-22.1%
-1.7%
Q3 24
-17.9%
6.5%
Q2 24
-34.6%
1.6%
Q1 24
-71.4%
8.1%
Capex Intensity
AXSM
AXSM
IDT
IDT
Q4 25
0.0%
1.8%
Q3 25
0.0%
1.7%
Q2 25
0.0%
1.8%
Q1 25
0.3%
1.6%
Q4 24
0.0%
1.7%
Q3 24
0.1%
1.7%
Q2 24
0.1%
1.6%
Q1 24
0.1%
1.5%
Cash Conversion
AXSM
AXSM
IDT
IDT
Q4 25
-0.45×
Q3 25
1.84×
Q2 25
3.49×
Q1 25
0.99×
Q4 24
0.01×
Q3 24
0.69×
Q2 24
1.71×
Q1 24
1.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

IDT
IDT

IDT Digital Payments$104.4M32%
IDT Global$60.2M19%
BOSS Revolution$45.7M14%
National Retail Solutions$39.3M12%
BOSS Revolution Money Transfer$36.3M11%
Net2phone$23.9M7%
Other$8.0M2%

Related Comparisons